Want to see IN:TARSONS full AI Analyst Report?
TARSONS Stock Chart & Stats
₹230.25
-₹6.55(-1.58%)
At close: 4:00 PM EST
₹230.25
-₹6.55(-1.58%)
Day’s Range― - ―
52-Week Range₹164.15 - ₹405.30
Previous CloseN/A
Volume39.72K
Average Volume (3M)2.32K
Market Cap
₹15.46B
Enterprise Value₹18.47B
Total Cash (Recent Filing)₹252.56M
Total Debt (Recent Filing)₹3.93B
Price to Earnings (P/E)106.9
Beta1.04
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)2.70
Shares Outstanding53,206,280
10 Day Avg. Volume1,556
30 Day Avg. Volume2,322
Financial Highlights & Ratios
PEG Ratio-1.29
Price to Book (P/B)1.51
Price to Sales (P/S)2.27
P/FCF Ratio-134.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.7
Revenue Forecast (FY)₹4.88B
Bulls Say, Bears Say
Bulls Say
Recurring Consumables BusinessTarsons' core business is recurring laboratory consumables (pipette tips, tubes, cultureware) sold to diagnostics, pharma, biotech and academia. That repeat-purchase model and compatibility with regulated workflows generate predictable baseline demand and customer stickiness over months to years.
Positive Operating Cash FlowConsistently positive and improving operating cash flow indicates the underlying business generates cash from operations, supporting working-capital needs and reinvestment. This durability reduces short-term liquidity strain and provides a foundation for funding growth or servicing obligations.
Balance-sheet ScaleA growing asset base and equity provide structural capacity to support manufacturing scale and absorb shocks. This larger balance sheet enhances ability to invest in capacity, secure supplier relations and underwrite expansion into export markets over the medium term.
Bears Say
Rising LeverageSharp debt growth increases financial risk if operating performance falters. Higher leverage raises interest and refinancing exposure, constrains flexibility for capex or M&A, and makes the company more vulnerable to margin volatility over the next several quarters if earnings don't recover.
Persistent Negative Free Cash FlowRepeated negative free cash flow despite positive OCF shows reinvestment or capex outstripping internal cash generation. Over time this forces reliance on external financing, limits debt paydown and reduces ability to return capital, weakening long-term financial resilience.
Weakened Profitability And MarginsA sustained downshift in margins and net income compresses earnings power and returns on equity. Without margin recovery, the company will struggle to convert revenue into cash, service higher debt, and sustain investments, impairing long-term competitiveness and shareholder returns.
Tarsons Products Limited News
TARSONS FAQ
What was Tarsons Products Limited’s price range in the past 12 months?
Tarsons Products Limited lowest stock price was ₹164.15 and its highest was ₹405.30 in the past 12 months.
What is Tarsons Products Limited’s market cap?
Tarsons Products Limited’s market cap is ₹15.46B.
When is Tarsons Products Limited’s upcoming earnings report date?
Tarsons Products Limited’s upcoming earnings report date is Aug 19, 2026 which is in 40 days.
How were Tarsons Products Limited’s earnings last quarter?
Tarsons Products Limited released its earnings results on May 22, 2026. The company reported ₹0.79 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.79.
Is Tarsons Products Limited overvalued?
According to Wall Street analysts Tarsons Products Limited’s price is currently Overvalued.
Does Tarsons Products Limited pay dividends?
Tarsons Products Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.86%. See more information on Tarsons Products Limited dividends here
What is Tarsons Products Limited’s EPS estimate?
Tarsons Products Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tarsons Products Limited have?
Tarsons Products Limited has 53,206,280 shares outstanding.
What happened to Tarsons Products Limited’s price movement after its last earnings report?
Tarsons Products Limited reported an EPS of ₹0.79 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.83%.
Which hedge fund is a major shareholder of Tarsons Products Limited?
Currently, no hedge funds are holding shares in IN:TARSONS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tarsons Products Limited
Established in 1983 and headquartered in Kolkata, India, Tarsons Products Limited specializes in the global manufacturing and distribution of plastic laboratory supplies and scientific instruments. The company's diverse product portfolio features disposable plastic labware, centrifuge and cryogenic equipment, liquid handling systems, and safety products. Its comprehensive catalog further encompasses items such as bottles, carboys, measuring cylinders, cell culture products, electrophoresis apparatus, microscopy and microbiology tools, vacuum desiccators, mini coolers, cryo boxes, beakers, test tube racks, pipette tips, petri dishes, centrifuge tubes, cryogenic and storage vials, Pasteur pipettes, and vortex mixers, among many others. These offerings are vital for research and applications across various scientific disciplines including molecular biology, cell culture, genomics, proteomics, and immunology.
Technical Analysis
Krebs Biochemicals & Industries Ltd.
―
Poly Medicure Limited
―
Vimta Labs Limited
―
Zim Laboratories Ltd.
―
Fischer Medical Ventures Ltd
―